Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NDA median approval time is shortened by 7% to 15.4 months in 1996.

Executive Summary

FDA 1996 MEDIAN NDA APPROVAL TIME OF 15.4 MONTHS IS 7% FASTER than the 1995 median time of 16.5 months, according to an analysis of 1996 review data released by FDA on Jan. 14. FDA approved 131 NDAs in 1996, a 60% increase over 1995's 82 NDAs. With eight biological approvals bringing the total number of new products approved to 139, FDA approved 63% more drugs and biologicals in 1996 than in 1995, when 85 new products were approved.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel